Furthermore, we have previously shown that residue 1369 also regulates MgATPase activity [2], providing a plausible mechanism by which the type 2 diabetes susceptibility variant S1369A in SUR1 may suppress insulin secretion in humans homozygous for the risk variant haplotype E23K/S1369A [24]. This evidence concerns the gene INS and type 2 diabetes mellitus.